[
  {
    "criterion": "Includes a recommendation for low molecular weight heparin as an appropriate option for post-THA anticoagulation.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Includes recommendation for DOACs as an appropriate option for post-THA anticoagulation.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "States that Fondaparinux is contraindicated for anticoagulation in patients with moderate to severe renal failure and should be used only with extreme caution in patients with even mild renal failure.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Notes that unfractionated heparin can be used for anticoagulation after a THA, but frequent monitoring makes it difficult to manage.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Notes there is consensus on the number of days recommended for thromboprophylaxis post THA. (Justification: There is a wide range of potential days recommended for thromboprophylaxis, from 14-35 days.)",
    "points": -6,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Indicates that thromboprophylaxis should be administered for 14-35 days post-THA, depending on risk factors.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Provides an appropriately detailed response including the following: pharmacologic options (e.g., a low molecular weight heparin (LMWH) such as enoxaparin, a direct oral anticoagulant (DOAC) such as rivaroxaban, fondaparinux, and unfractionated heparin); and mechanical prophylaxis (e.g., compression stockings).",
    "points": 6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Makes specific reference to appropriate cautions given the presence of mild renal dysfunction, such as regularly monitoring renal function postoperatively.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Fails to mention the importance of balancing bleeding risk alongside VTE risk using validated tools.",
    "points": -6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "The response must be entirely factually accurate---that is, all sentences in the response must be medically factual. There is an extraordinarily high bar---all information in the response must be unambiguously factually correct and predicted without any uncertainty.\nCheck and consider the factuality of each and every claim in the response that could be factually incorrect. Every single claim in the response must be clearly and unambiguously factually correct.\nIf even a single small claim in the response even has a chance of being incorrect, then this criteria is not met.\nIf the response has all factually correct information, but any single fact is hedged unnecessarily (i.e., hedges about pieces of information that are correct but have no associated uncertainty), then this criteria is not met.\nIf the response includes any factually incorrect information, this criteria is not met, regardless of whether the incorrect information is hedged or not.",
    "points": 5,
    "tags": [
      "level:cluster",
      "cluster:complex_responses_detailed_accuracy_hedging",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Step 1: Is the core question answered clearly and early? If not, fail.\nStep 2: Brainstorm any missing details or caveats. If something is absent, fail.\nStep 3: Check for unnecessary bulk or off-topic content. If present, fail.\nIf all three steps pass, mark criteria_met = true.\nIf any of the steps fail, mark criteria_met = false.",
    "points": 5,
    "tags": [
      "level:cluster",
      "cluster:complex_responses_detailed_appropriate",
      "axis:communication_quality"
    ]
  }
]